REG - Zotefoams PLC - Issue of Equity

ZotefoamsAnnouncement

25/08/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230825:nRSY3831Ka&default-theme=true

RNS Number : 3831K  Zotefoams PLC  25 August 2023

Zotefoams plc

 

Issue of Equity

 

25 August 2023 - Zotefoams plc (LSE: ZTF) announces that it will allot and
issue 225,000 new ordinary shares of five pence each in the capital of the
Company ("Ordinary Shares") on 30 August 2023, (the "New Shares").

 

The New Shares, which will rank pari passu with the existing Ordinary Shares
in issue, will be allotted and issued to the Zotefoams plc 2007 Employee
Benefit Trust (the "EBT") at the par value of five pence each in order to
satisfy future exercises of awards under the Group's share incentive schemes.

 

The EBT will thereafter hold a total of 283,135 Ordinary Shares, representing
approximately 0.6 percent of the enlarged issued share capital of the Company.

 

Applications have been made to the Financial Conduct Authority (the "FCA") for
the admission of the New Shares to the premium listing segment of the Official
List of the FCA and to London Stock Exchange plc for admission to trading of
the New Shares on its main market for listed securities (together,
"Admission"). Admission is expected to become effective at 8.00 a.m. on 30
August 2023.

 

Following Admission, the Company will have 48,846,234 Ordinary Shares in
issue. There are no shares held in treasury. Therefore, following Admission
the total number of voting rights in the Company will be 48,846,234 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their voting rights
interest, or a change to that interest, in the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

 Zotefoams plc                             +44 (0) 208 664 1600
 David Stirling, Group CEO
 Gary McGrath, Group CFO

 IFC Advisory (Financial PR & IR)          +44 (0) 203 934 6630
 Graham Herring

 Tim Metcalfe

 Zach Cohen

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology,
delivering optimal material solutions for the benefit of society. Utilising a
variety of unique manufacturing processes, including environmentally friendly
nitrogen expansion for lightweight AZOTE(®) polyolefin and ZOTEK(®)
high-performance foams, Zotefoams sells to diverse markets worldwide.
Zotefoams uses its own cellular materials to manufacture T-FIT(®) advanced
insulation for demanding industrial markets. Zotefoams also owns and licenses
patented microcellular foam technology to reduce plastic use in extrusion
applications and for ReZorce(®) mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam
products manufacture and conversion), Massachusetts, USA, Stilling, Denmark
(microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com (http://www.zotefoams.com)

AZOTE(®), ZOTEK(®), ReZorce(®) and T-FIT(®) are registered trademarks of
Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEPPUWURUPWGCC